Merit Medical Systems Inc (MMSI)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $5.19B
Last updated: Nov 17, 2026 at 11:06 AM ET
Merit Medical Systems Inc (MMSI) Financials: Revenue, Profit and Cash Flow
Merit Medical Systems reported revenue of $1.52B for the fiscal year ended Dec 31, 2025, up 11.8% from the year before. That year, net income was $128.49M with a net margin of 8.5%, operating cash flow was $297.37M and free cash flow was $215.66M. The quarter ended Sep 30, 2026 had revenue of $416.24M and net income of $42.31M.
Revenue and Margins
The operating margin was 12.2% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $603.84M, a compound annual rate of 10.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1.52B | +11.8% | 48.7% | 12.2% | 8.5% |
| Dec 2024 | $1.36B | +7.9% | 47.4% | 11.5% | 8.9% |
| Dec 2023 | $1.26B | +9.2% | 46.4% | 9.9% | 7.5% |
| Dec 2022 | $1.15B | +7.1% | 45.1% | 7.6% | 6.5% |
| Dec 2021 | $1.07B | +11.5% | 45.2% | 5.7% | 4.5% |
| Dec 2020 | $963.88M | -3.1% | 41.6% | -0.2% | -1.0% |
| Dec 2019 | $994.85M | +12.7% | 43.5% | 1.6% | 0.5% |
| Dec 2018 | $882.75M | +21.3% | 44.7% | 6.6% | 4.8% |
| Dec 2017 | $727.85M | +20.5% | 44.8% | 4.5% | 3.8% |
| Dec 2016 | $603.84M | N/A | 43.9% | 5.8% | 3.3% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 6.8% from the year before. In the quarter ended Sep 2026, net income rose 52.5% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.52B | $1.36B | $1.26B | $1.15B | $1.07B | $963.88M | $994.85M | $882.75M | $727.85M | $603.84M |
| Cost of revenue | $777.64M | $713.18M | $673.49M | $631.88M | $589.42M | $562.70M | $562.49M | $487.98M | $401.60M | $338.81M |
| Gross profit | $738.27M | $643.33M | $583.87M | $519.10M | $485.33M | $401.18M | $432.37M | $394.77M | $326.25M | $265.02M |
| Research and development | $97.35M | $87.47M | $84.28M | $82.18M | $71.25M | $57.79M | $66.14M | $60.18M | $63.54M | $45.69M |
| Operating income | $184.72M | $155.69M | $123.94M | $87.56M | $60.92M | -$1.56M | $15.43M | $58.62M | $33.07M | $34.88M |
| Net income | $128.49M | $120.36M | $94.41M | $74.52M | $48.45M | -$9.84M | $5.45M | $42.02M | $27.52M | $20.12M |
| EBITDA | $322.53M | $276.38M | $228.05M | $180.62M | $154.69M | $103.45M | $119.83M | $128.89M | $97.36M | $78.64M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $416.24M | $418.84M | $381.88M | $393.94M | $384.16M | $382.46M | $355.35M | $355.16M | $339.85M | $338.00M | $323.51M | $324.51M |
| Gross profit | $200.63M | $215.17M | $184.80M | $195.35M | $186.41M | $184.49M | $172.02M | $172.98M | $157.53M | $161.10M | $151.72M | $150.53M |
| Operating income | $58.76M | $60.40M | $44.16M | $54.20M | $42.61M | $46.88M | $41.03M | $36.56M | $37.26M | $45.95M | $35.92M | $33.61M |
| Net income | $42.31M | $38.80M | $40.99M | $38.01M | $27.75M | $32.58M | $30.15M | $27.95M | $28.44M | $35.73M | $28.24M | $27.63M |
Balance Sheet
As of Dec 2025, total debt of $744.91M exceeded cash and equivalents by $298.51M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.69B | $2.42B | $2.33B | $1.66B | $1.65B | $1.66B | $1.76B | $1.62B | $1.11B | $942.80M |
| Current assets | $1.04B | $923.77M | $1.11B | $529.08M | $482.21M | $429.71M | $454.54M | $429.83M | $316.12M | $243.42M |
| Cash and equivalents | $446.40M | $376.71M | $587.04M | $58.41M | $67.75M | $56.92M | $44.32M | $67.36M | $32.34M | $19.17M |
| Total liabilities | $1.10B | $1.04B | $1.12B | $519.57M | $608.50M | $705.82M | $807.38M | $687.24M | $435.48M | $444.61M |
| Short-term debt | $10.88M | $10.33M | $12.09M | $11.25M | $8.44M | $7.50M | $7.50M | $22.00M | $19.46M | $10.00M |
| Long-term debt | $734.04M | $729.55M | $823.01M | $186.76M | $234.40M | $343.72M | $431.98M | $373.15M | $259.01M | $314.37M |
| Shareholder equity | $1.58B | $1.38B | $1.20B | $1.14B | $1.04B | $958.58M | $949.94M | $932.77M | $676.33M | $498.19M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.92B | $2.86B | $2.72B | $2.69B | $2.63B | $2.59B | $2.47B | $2.42B | $2.38B | $2.37B | $2.33B | $2.33B |
| Total liabilities | $1.18B | $1.18B | $1.09B | $1.10B | $1.10B | $1.10B | $1.04B | $1.04B | $1.05B | $1.09B | $1.09B | $1.12B |
| Cash and equivalents | $503.55M | $448.70M | $488.08M | $448.50M | $392.46M | $341.82M | $395.53M | $376.71M | $523.13M | $636.66M | $581.92M | $587.04M |
| Shareholder equity | $1.74B | $1.68B | $1.63B | $1.58B | $1.53B | $1.49B | $1.43B | $1.38B | $1.32B | $1.28B | $1.24B | $1.20B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 72.5% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $297.37M | $220.80M | $145.15M | $114.29M | $147.23M | $165.27M | $77.81M | $86.53M | $62.73M | $53.60M |
| Capital expenditures | $81.72M | $35.14M | $34.29M | $45.03M | $27.94M | $45.99M | $78.17M | $63.32M | $38.62M | $32.84M |
| Free cash flow | $215.66M | $185.66M | $110.86M | $69.26M | $119.29M | $119.28M | -$360.00K | $23.21M | $24.10M | $20.76M |
| Dividends paid | N/A | N/A | N/A | $2.47M | $576.00K | $866.00K | N/A | $0 | $0 | $0 |
| Share repurchases | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $366.00K | $816.00K | $0 |
| Investing cash flow | -$247.39M | -$368.65M | -$175.35M | -$57.40M | -$37.16M | -$58.65M | -$134.48M | -$378.82M | -$146.76M | -$159.11M |
| Financing cash flow | $16.00M | -$60.01M | $559.27M | -$60.26M | -$98.44M | -$95.71M | $33.53M | $328.28M | $96.52M | $121.09M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $65.27M | $69.28M | $40.68M | $98.51M | $74.98M | $83.31M | $40.57M | $68.74M | $47.33M | $68.51M | $36.22M | $62.25M |
| Capital expenditures | $12.35M | $17.33M | $16.01M | $24.46M | $22.44M | $13.75M | $21.06M | $3.47M | $9.36M | $10.63M | $11.68M | $7.14M |
| Free cash flow | $52.93M | $51.95M | $24.67M | $74.05M | $52.54M | $69.56M | $19.51M | $65.27M | $37.97M | $57.88M | $24.53M | $55.11M |
Frequently Asked Questions About MMSI
What is Merit Medical Systems' annual revenue?
Merit Medical Systems reported revenue of $1.52B for the fiscal year ended Dec 31, 2025.
How fast is Merit Medical Systems' revenue growing?
Revenue was up 11.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 9.6%.
Is Merit Medical Systems profitable?
Yes. Merit Medical Systems reported net income of $128.49M for the fiscal year ended Dec 31, 2025, with a net margin of 8.5%.
How much free cash flow does MMSI generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $297.37M minus capital expenditures of $81.72M produced free cash flow of $215.66M.
How much debt does Merit Medical Systems have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $734.04M, short-term debt of $10.88M and cash and equivalents of $446.40M.
MMSI pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts